MetLife Inc (MET) stock
METNYSELife InsuranceFiscal year ends December 31Also trades as MET.PA, MET.PE, MET.PF
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 6, 2026Score 10/3039% above fair value
$102.65+0.78 (+0.77%)
Close on Nov 13, 2026Market cap $65.23BP/E 13.4Yield 2.19%
MetLife r&d expenses
Research and development expenses are spending on new products and technology.
No r&d expenses figures for MetLife
MetLife has not reported this figure in its SEC filings, or the share price needed to calculate it is not available yet.
See a number that looks wrong?